![]() |
市场调查报告书
商品编码
1968457
诊断影像服务市场-全球产业规模、份额、趋势、机会、预测:按模式、应用、区域和竞争格局划分,2021-2031年Diagnostic Imaging Services Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Modality, By Application, By Region & Competition, 2021-2031F |
||||||
全球诊断影像服务市场预计将从 2025 年的 6,476.4 亿美元成长到 2031 年的 9,275.7 亿美元,复合年增长率为 6.17%。
该领域涵盖医学影像诊断技术,例如X光、电脑断层扫描(CT)、磁振造影(MRI)和超音波,这些技术用于对人体进行可视化,以达到诊断和治疗的目的。市场成长的主要驱动因素是全球人口老化以及需要频繁、精准监测的慢性疾病数量不断增加。此外,影像技术的进步正在扩大临床应用范围,并提升病患照护能力。例如,英国皇家放射学院的一份报告预测,到2024年,英国对CT和MRI成像的需求英国增加8%,凸显了主要医疗保健系统面临的日益增长的压力和不断提高的使用率。
| 市场概览 | |
|---|---|
| 预测期 | 2027-2031 |
| 市场规模:2025年 | 6476.4亿美元 |
| 市场规模:2031年 | 9275.7亿美元 |
| 复合年增长率:2026-2031年 | 6.17% |
| 成长最快的细分市场 | X射线 |
| 最大的市场 | 北美洲 |
儘管需求强劲,市场仍面临劳动力能力和营运成本的重大挑战。放射科医师和技术人员的严重短缺限制了医疗机构应对扫描需求激增的能力,常常导致诊断延误。设备所需的高额资本投入以及外包积压病例处理服务带来的经济负担进一步加剧了这一瓶颈。因此,无法扩大人员配备规模以满足诊断影像需求,成为全球诊断影像服务顺利扩张的主要障碍。
慢性病和文明病的日益普遍是全球诊断影像服务市场的主要驱动力。随着心血管疾病和恶性肿瘤等疾病的日益蔓延,临床上对先进影像技术在精准诊断、分期和后续观察的依赖性也日益增强。这一趋势在肿瘤学领域尤为显着,筛检和诊断程序的数量正在稳步增长,因为早期发现对于提高患者存活率至关重要。根据美国癌症协会发布的《2024年癌症事实与数据》报告,预计2024年美国将新增超过200万例癌症病例,凸显了日益沉重的疾病负担,也凸显了对全面影像支持的需求。
第二个主要驱动力是技术进步与人工智慧(AI)的融合。这些技术正在透过提高诊断准确性和营运效率来改变医疗服务的提供方式。人工智慧演算法的日益普及,旨在实现影像分析自动化、缩短检查时间并优先处理急诊病例,这对于应对放射科面临的巨大压力至关重要。根据MedTech Dive在2024年10月报道,美国食品药物管理局(FDA)的数据显示,截至2024年8月,该机构已核准了950种人工智慧驱动的医疗设备,其中绝大多数(723种)应用于放射学领域。这些技术对于缓解系统性压力至关重要,英国国家医疗服务体系(NHS England)的数据显示,截至2024年8月,约有156万名患者正在等待诊断检测,这充分说明了这些技术的必要性。
合格放射科医师和技术人员的短缺是限制全球诊断影像服务市场成长的一大结构性障碍。即使医疗机构能够部署先进的影像系统,缺乏操作这些设备和解读扫描结果的熟练人员也会造成严重的营运瓶颈。设备可用性和人员能力之间的这种差距迫使医疗机构限制服务量,导致患者等待时间延长,并阻碍了诊断能力的自然扩张。人员不足会导致医疗机构无法最大限度地利用其影像设备,从而直接限制产生收入和服务扩充性。
因此,医疗机构为弥补人员短缺而增加的营运成本正在急剧上升。医疗系统越来越依赖昂贵的临时人员和外包影像判读服务来清理积压的未处理病例,从而将大量资金从基础设施投资中转移出去。英国皇家放射学院在2024年报告称,英国临床放射科顾问将出现30%的缺口。这种长期的劳动力短缺迫使医疗机构优先考虑维持营运而非扩张,阻碍了诊断影像领域的更广泛发展。
将诊断影像服务转移到门诊和护理机构,从根本上改变了病患的就医路径,使诊断资源不再集中在不堪重负的急诊医院。这一趋势的驱动力在于消除营运瓶颈、降低检测成本,并透过社区服务模式提升病患就医便利性。政府和私人医疗机构正积极拓展此类网络,旨在管理候诊名单,并将诊断流程与急诊流程选择性地分开。根据英国国家医疗服务体系(NHS)英格兰分部2024年9月发布的社区诊断中心最新进展,这项全国性倡议已成功扩展至165个运作点,自启动以来已完成超过900万次检测、检查和扫描,凸显了对分散式服务的强劲需求。
治疗诊断学(治疗性诊断)和精准核医学的出现,标誌着诊断影像与标靶治疗直接结合的变革性发展。这种方法利用特定的放射性药物来识别癌细胞上的独特分子标靶,并进行局部治疗,从而有效地将诊断和治疗整合到一个精准的工作流程中。领先製造商的显着收入成长推动了这些药物的快速商业性,创造了超越传统硬体的新价值。例如,GE医疗在2023年第四季财报中宣布,其药物诊断部门第四季实现了23%的有机收入成长,凸显了其对分子影像解决方案日益增长的市场依赖。
The Global Diagnostic Imaging Services Market is projected to expand from USD 647.64 Billion in 2025 to USD 927.57 Billion by 2031, reflecting a CAGR of 6.17%. This sector encompasses the provision of medical imaging procedures such as X-ray, computed tomography (CT), magnetic resonance imaging (MRI), and ultrasound, which are utilized to visualize the human body for diagnostic and treatment purposes. Market growth is primarily driven by an aging global population and the increasing prevalence of chronic diseases, which require frequent and accurate monitoring. Additionally, technological advancements in imaging modalities are broadening clinical applications and improving patient throughput; for instance, the Royal College of Radiologists reported an 8% increase in demand for CT and MRI imaging activity in the United Kingdom in 2024, highlighting the intensifying pressure and rising utilization rates within major healthcare systems.
| Market Overview | |
|---|---|
| Forecast Period | 2027-2031 |
| Market Size 2025 | USD 647.64 Billion |
| Market Size 2031 | USD 927.57 Billion |
| CAGR 2026-2031 | 6.17% |
| Fastest Growing Segment | X-ray |
| Largest Market | North America |
Despite these positive demand indicators, the market encounters significant hurdles related to workforce capacity and operational costs. A critical shortage of radiologists and technical staff restricts the ability of healthcare facilities to handle the growing volume of scan requests, frequently leading to diagnostic delays. This bottleneck is further aggravated by the high capital expenditure necessary for equipment and the financial burden of outsourcing reporting services to clear backlogs. Consequently, the inability to scale staffing levels to match imaging demand remains a substantial barrier preventing the seamless expansion of diagnostic imaging services worldwide.
Market Driver
The rising prevalence of chronic and lifestyle-related diseases acts as a primary catalyst for the global diagnostic imaging services market. As conditions such as cardiovascular disorders and malignancies become more widespread, clinical reliance on advanced imaging modalities for precise diagnosis, staging, and treatment monitoring intensifies. This trend is particularly notable in oncology, where early detection is vital for patient survival, driving a sustained increase in screening and diagnostic procedure volumes. According to the American Cancer Society's 'Cancer Facts & Figures 2024' report, the United States is projected to see over 2 million new cancer cases in 2024, a milestone that emphasizes the growing disease burden requiring comprehensive imaging support.
Technological advancements and the integration of artificial intelligence (AI) serve as the second major driver, reshaping service delivery by improving diagnostic precision and operational efficiency. AI algorithms are increasingly being deployed to automate image analysis, reduce scan times, and prioritize urgent cases, which is essential for managing the high demand placed on radiology departments. As reported by MedTech Dive in October 2024, FDA data indicates that as of August 2024, the agency had authorized 950 AI-enabled medical devices, with radiology applications comprising the majority at 723 devices. These technologies are crucial for mitigating systemic pressures, a need highlighted by NHS England data showing approximately 1.56 million patients waiting for a diagnostic test as of August 2024.
Market Challenge
The shortage of qualified radiologists and technical staff presents a significant structural barrier to the growth of the Global Diagnostic Imaging Services Market. Although healthcare providers can acquire advanced imaging systems, the scarcity of specialized personnel needed to operate these machines and interpret scans creates a severe operational bottleneck. This disconnect between equipment availability and workforce capacity compels facilities to limit service volumes, resulting in extended patient wait times and hindering the organic expansion of diagnostic capabilities. Without an adequate workforce, facilities are unable to maximize the utilization of their imaging assets, which directly constrains revenue generation and service scalability.
As a result, the market contends with inflated operational expenditures as providers attempt to bridge this staffing gap. Healthcare systems increasingly rely on expensive temporary staffing or outsourced reporting services to clear mounting backlogs, diverting critical capital away from infrastructure investment. The Royal College of Radiologists reported in 2024 that the United Kingdom faced a 30 percent shortfall in clinical radiology consultants. This chronic labor deficit forces healthcare organizations to prioritize operational maintenance over expansion, thereby impeding the broader development of the diagnostic imaging sector.
Market Trends
The shift of imaging services toward outpatient and ambulatory care settings is fundamentally altering patient pathways by decentralizing diagnostic access away from overburdened acute hospital facilities. This trend is driven by the need to alleviate operational bottlenecks, lower procedural costs, and enhance patient convenience through community-based delivery models. Governments and private providers are aggressively expanding these networks to manage waitlists and separate elective diagnostics from emergency workflows. According to an NHS England update in September 2024 regarding Community Diagnostic Centres, the national initiative has successfully scaled to 165 operational sites, delivering over 9 million tests, checks, and scans since the program began, validating the strong demand for decentralized services.
The emergence of theranostics and precision nuclear medicine represents a transformative evolution wherein diagnostic imaging is directly coupled with targeted therapeutic delivery. This approach employs specific radiopharmaceuticals to identify unique molecular targets on tumor cells and deliver localized treatment, effectively merging diagnosis and therapy into a single precision workflow. The rapid commercial adoption of these agents is evidenced by significant revenue increases for key industry manufacturers, creating value streams beyond traditional hardware. For example, GE HealthCare reported in its 'Fourth Quarter 2023 Financial Results' that its Pharmaceutical Diagnostics segment achieved 23% organic revenue growth in the fourth quarter, underscoring the intensifying market reliance on molecular imaging solutions.
Report Scope
In this report, the Global Diagnostic Imaging Services Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:
Company Profiles: Detailed analysis of the major companies present in the Global Diagnostic Imaging Services Market.
Global Diagnostic Imaging Services Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report: